Literature DB >> 34628936

IL (Interleukin)-17A Acts in the Brain to Drive Neuroinflammation, Sympathetic Activation, and Hypertension.

Yiling Cao1, Yang Yu1, Baojian Xue2, Ye Wang3, Xiaolei Chen4, Terry G Beltz2, Alan Kim Johnson2,5,6, Shun-Guang Wei1,5,3.   

Abstract

[Figure: see text].

Entities:  

Keywords:  angiotensin II; autonomic nervous system; blood pressure; cytokines; hemodynamics; paraventricular hypothalamic nucleus

Mesh：

Substances：

Year:  2021        PMID： 34628936      PMCID： PMC8516065          DOI： 10.1161/HYPERTENSIONAHA.121.18219

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


  42 in total

Review 1.  IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.

Authors:  Dirk W Luchtman; Erik Ellwardt; Catherine Larochelle; Frauke Zipp
Journal:  Cytokine Growth Factor Rev       Date:  2014-07-29       Impact factor: 7.638

2.  Early interference with p44/42 mitogen-activated protein kinase signaling in hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension.

Authors:  Yang Yu; Bao-Jian Xue; Zhi-Hua Zhang; Shun-Guang Wei; Terry G Beltz; Fang Guo; Alan Kim Johnson; Robert B Felder
Journal:  Hypertension       Date:  2013-02-25       Impact factor: 10.190

Review 3.  Neuroinflammation and sympathetic overactivity: Mechanisms and implications in hypertension.

Authors:  Dhanush Haspula; Michelle A Clark
Journal:  Auton Neurosci       Date:  2018-01-12       Impact factor: 3.145

4.  Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor.

Authors:  Z Yao; W C Fanslow; M F Seldin; A M Rousseau; S L Painter; M R Comeau; J I Cohen; M K Spriggs
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

5.  IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis.

Authors:  A Francesca Setiadi; Alexander R Abbas; Surinder Jeet; Kit Wong; Antje Bischof; Ivan Peng; James Lee; Meire Bremer; Erica L Eggers; Jason DeVoss; Tracy Staton; Ann Herman; H-Christian von Büdingen; Michael J Townsend
Journal:  J Neuroimmunol       Date:  2019-04-21       Impact factor: 3.478

6.  Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice.

Authors:  Kazuhide Hayakawa; Takafumi Nakano; Keiichi Irie; Sei Higuchi; Masayuki Fujioka; Kensuke Orito; Katsunori Iwasaki; Guang Jin; Eng H Lo; Kenichi Mishima; Michihiro Fujiwara
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-09       Impact factor: 6.200

Review 7.  Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease.

Authors:  Reiko M Onishi; Sarah L Gaffen
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

Review 8.  IL-17 Signaling: The Yin and the Yang.

Authors:  Nilesh Amatya; Abhishek V Garg; Sarah L Gaffen
Journal:  Trends Immunol       Date:  2017-02-20       Impact factor: 16.687

Review 9.  The role of IL-17 in CNS diseases.

Authors:  Ari Waisman; Judith Hauptmann; Tommy Regen
Journal:  Acta Neuropathol       Date:  2015-02-26       Impact factor: 17.088

10.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190
View more
  2 in total

Review 1.  Gut Microbiome and Neuroinflammation in Hypertension.

Authors:  Elaine M Richards; Jing Li; Bruce R Stevens; Carl J Pepine; Mohan K Raizada
Journal:  Circ Res       Date:  2022-02-03       Impact factor: 17.367

Review 2.  Maternal and Adult Interleukin-17A Exposure and Autism Spectrum Disorder.

Authors:  Masashi Fujitani; Hisao Miyajima; Yoshinori Otani; Xinlang Liu
Journal:  Front Psychiatry       Date:  2022-02-08       Impact factor: 4.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.